PAPER Kim DM, Ryu SW, Choi C
SEARCH RESULTS
331159 RESULTS
PAPER Lee AM, Paulsson JF, Cruite J, Andaya AA, Trifilo MJ, Oldstone MB
Extraneural manifestations of prion infection in GPI-anchorless transgenic mice.
Virology. 2011 Mar 1;411(1):1-8. PubMed: 21227476PAPER Zhou D, Zhang M, Ye X, Gu C, Piser TM, Lanoue BA, Schock SA, Cheng YF, Grimm SW
In vitro metabolism of α7 neuronal nicotinic receptor agonist AZD0328 and enzyme identification for its N-oxide metabolite.
Xenobiotica. 2011 Mar;41(3):232-42. PubMed: 21226652PAPER Choi SH, Li Y
Elevated levels of BMP6 impair neurogenesis in Alzheimer's disease.
J Neurosci. 2011 Jan 12;31(2):371-2. PubMed: 21228148PAPER Krueger F, Pardini M, Huey ED, Raymont V, Solomon J, Lipsky RH, Hodgkinson CA, Goldman D, Grafman J
The role of the Met66 brain-derived neurotrophic factor allele in the recovery of executive functioning after combat-related traumatic brain injury.
J Neurosci. 2011 Jan 12;31(2):598-606. PubMed: 21228168PAPER Hefendehl JK, Wegenast-Braun BM, Liebig C, Eicke D, Milford D, Calhoun ME, Kohsaka S, Eichner M, Jucker M
Long-term in vivo imaging of β-amyloid plaque appearance and growth in a mouse model of cerebral β-amyloidosis.
J Neurosci. 2011 Jan 12;31(2):624-9. PubMed: 21228171PAPER Hongpaisan J, Sun MK, Alkon DL
PKC ε activation prevents synaptic loss, Aβ elevation, and cognitive deficits in Alzheimer's disease transgenic mice.
J Neurosci. 2011 Jan 12;31(2):630-43. PubMed: 21228172PAPER Roberson ED, Halabisky B, Yoo JW, Yao J, Chin J, Yan F, Wu T, Hamto P, Devidze N, Yu GQ, Palop JJ, Noebels JL, Mucke L
Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease.
J Neurosci. 2011 Jan 12;31(2):700-11. PubMed: 21228179PAPER Breitner JC
Apolipoprotein e, Alzheimer's disease, and amyloid: do we have the cart before the horse?
J Alzheimers Dis. 2011;23(1):171-2. PubMed: 21228459PAPER
Upcoming meetings related to Alzheimer's disease.
Rev Neurol. 2011 Jan 16;52(2):101-111. PubMed: 21228460PAPER Hori K, Konishi K, Watanabe K, Uchida H, Tsuboi T, Moriyasu M, Tominaga I, Hachisu M
Influence of anticholinergic activity in serum on clinical symptoms of Alzheimer's disease.
Neuropsychobiology. 2011;63(3):147-53. PubMed: 21228606PAPER Baek MJ, Kim HJ, Ryu HJ, Lee SH, Han SH, Na HR, Chang Y, Chey JY, Kim S
The usefulness of the story recall test in patients with mild cognitive impairment and Alzheimer's disease.
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2011 Mar;18(2):214-29. PubMed: 21229403PAPER Gallagher D, Coen R, Kilroy D, Belinski K, Bruce I, Coakley D, Walsh B, Cunningham C, Lawlor BA
Anxiety and behavioural disturbance as markers of prodromal Alzheimer's disease in patients with mild cognitive impairment.
Int J Geriatr Psychiatry. 2011 Feb;26(2):166-72. PubMed: 21229599PAPER Supprian T, Höhl W
[Treatment of dementia].
MMW Fortschr Med. 2010 Nov 4;152(44):54-7; quiz 58. PubMed: 21158177PAPER Blesa González R, Boada Rovira M, Martínez Parra C, Gil-Saladié D, Almagro CA, Gobartt Vázquez AL,
Evaluation of the convenience of changing the rivastigmine administration route in patients with Alzheimer disease.
Neurologia. 2011 Jun;26(5):262-271. PubMed: 21227548Current Filters
No filters selected